RXRX
Recursion Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.60B
P/E Ratio
—
EPS
$-1.16
Beta
1.05
52W High
$7.18
52W Low
$2.77
50-Day MA
$3.29
200-Day MA
$4.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
Fundamentals
| Revenue (TTM) | $66.41M |
| Gross Profit (TTM) | $-428.74M |
| EBITDA | $-501.23M |
| Operating Margin | -1986.00% |
| Return on Equity | -57.20% |
| Return on Assets | -27.70% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $1.93 |
| Price-to-Book | 1.56 |
| Price-to-Sales (TTM) | 24.06 |
| EV/Revenue | 15.45 |
| EV/EBITDA | -5.31 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -56.10% |
| Shares Outstanding | $524.68M |
| Float | $512.96M |
| % Insiders | 2.27% |
| % Institutions | 68.55% |
Historical Volatility
HV 10-Day
48.18%
HV 20-Day
49.44%
HV 30-Day
57.29%
HV 60-Day
52.72%
HV Rank
21.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.64 target)
2
Strong Buy1
Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026